Mifamurtide sodium TP2332L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults. It was approved in Europe in March 2009.
CAS nr:
90825-43-7
Purity:
98%
Molecular Weight:
1259,49
SMILES:
CCCCCCCCCCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCC)=O)COP([O-])(OCCNC([C@@H](NC(CC[C@H](C(N)=O)NC([C@@H](NC([C@H](O[C@H]([C@H](C=O)NC(C)=O)[C@@H]([C@@H](CO)O)O)C)=O)C)=O)=O)C)=O)=O)=O.[Na+]
Formula:
C59H108N6NaO19P
Pathway:
Target:
